Sana Biotechnology Announces Appointments to its Board of Directors
Sana Biotechnology Announces Appointments to its Board of Directors Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, join Sana Board of Directors News provided by Share this article Share this article SEATTLE, Jan. 8, 2021 /PRNewswire/ -- Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, have been appointed to the Sana Board of Directors. "Josh, Alise, and Michelle all share a passion and commitment to our long-term vision of engineering cell...